6080 Falls Rd, Suite 204, 
Baltimore, MD 

Overview

John Nesbitt is a Hematologist practicing medicine in Baltimore, Maryland.

His clinical expertise encompasses Polycythemia Vera, Small Lymphocytic Lymphoma (SLL), Hemolytic Crisis, and Congenital Hemolytic Anemia.

He is actively involved in clinical research, co-authoring 1 peer reviewed article.

Specialties

Hematology

Licenses

Internal Medicine in MD

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

6080 Falls Rd, Suite 204, Baltimore, MD 21209

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Total Publications

Similar Doctors
Expertise in
14
conditions
Hematology | Oncology
Expertise in
14
conditions
Hematology | Oncology
Referral may be required

Johns Hopkins Kimmel Cancer Center At Green Spring Station

10803 Falls Rd, Ste 1500, 
Lutherville, MD 
 (3.5 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine. Dr. Hann is currently accepting new patients.

Expertise in
86
conditions
Hematology | Oncology
Expertise in
86
conditions
Hematology | Oncology
Referral may be required

University Of Maryland Hematology And Oncology Practice

7501 Osler Drive, Suite 102, 
Towson, MD 
 (2.3 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Syed Nasir is a Hematologist and an Oncologist practicing medicine in Towson, Maryland. Dr. Nasir is highly rated in 86 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast. Dr. Nasir is board certified in American Board Of Internal Medicine - Medical Oncology, 2017. Dr. Nasir is currently accepting new patients.

Expertise in
33
conditions
Oncology | Hematology | Hematology Oncology
Expertise in
33
conditions
Oncology | Hematology | Hematology Oncology
Referral may be required

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10803 Falls Road, Pavilion III STE 1500, 
Lutherville, MD 
 (4.6 miles away)
Languages Spoken:
English, Dutch, French
Accepting New Patients
Offers Telehealth

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Swinnen is board certified in American Board Of Internal Medicine. Dr. Swinnen is currently accepting new patients.

Expertise in
26
conditions
Hematology | Oncology
Expertise in
26
conditions
Hematology | Oncology
Referral may be required

Sidney Kimmel Comprehensive Cancer Center

401 North Broadway Street, Weinberg BLDG, Weinberg BLDG, 
Baltimore, MD 
 (6.1 miles away)
Languages Spoken:
English
Accepting New Patients

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.

Expertise in
25
conditions
Hematology
Expertise in
25
conditions
Hematology
Referral may be required

Greater Baltimore Medical Center Inc.

6569 N Charles St Ste 201, 
Towson, MD 
 (2.2 miles away)
Languages Spoken:
English, Mandarin
Accepting New Patients
Offers Telehealth

Mei Tang is a Hematologist practicing medicine in Towson, Maryland. Dr. Tang is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Large-Cell Immunoblastic Lymphoma, Myeloproliferative Neoplasms (MPN), and Multiple Myeloma. Dr. Tang is currently accepting new patients.

Expertise in
27
conditions
Oncology | Hematology
Expertise in
27
conditions
Oncology | Hematology
Referral may be required

Sidney Kimmel Comprehensive Cancer Center

401 North Broadway Street, Weinberg BLDG, Weinberg BLDG, 
Baltimore, MD 
 (6.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. DeZern is a Professor of Oncology and Medicine at The Johns Hopkins University School of Medicine. She is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. DeZern has expertise in aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, acute myeloid leukemia, and bone marrow transplantation. Dr. DeZern received her medical degree at The Johns Hopkins University School of Medicine. She completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology and hematology, as well as obtained a Masters in Clinical Investigations at the Bloomberg School of Public health. Dr. DeZern is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. DeZern’s principle research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of bone marrow failure (aplastic anemia and myelodysplastic syndromes). She has specific expertise in the use of alternative donor bone marrow transplantation in patients with severe aplastic anemia and trials of novel therapeutics for patients with myelodysplastic syndromes. Additionally, she has taken a rigorous approach to the study of diagnostics and supportive case (such as transfusion practices) in these patient populations. She is or has been the Principal Investigator for a number of multicenter trials in collaboration with the MDS Clinical Research Consortium, the Eastern Co-operative Oncology Group (ECOG)-ACRIN and now the Bone Marrow Trials Clinical Trials Network (BMTCTN). She is the Study Chair for the multi-site BMTCTN study (CHAMP) investigating the role of haploidentical donor transplantation using post-transplantation cyclophosphamide in patients with relapsed several aplastic anemia. Dr. DeZern is the local PI as well as the Deputy Chair for The National MDS Study, a collaborative natural history study of the NHLBI and the NCI. As a clinical investigator with a focus on translation of novel treatments to the clinic, Dr. DeZern’s goal is to improve outcomes for patients with bone marrow failure at the bedside and in her research environment. Dr. Dezern is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dezern is board certified in American Board Of Internal Medicine. Dr. Dezern is currently accepting new patients.

Frequently Asked Questions about Dr. John A. Nesbitt

How do I make an appointment with Dr. John A. Nesbitt?

You can book an appointment with Dr. John A. Nesbitt by calling their office at 410-323-2757. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John A. Nesbitt a top-rated expert for Polycythemia Vera?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John A. Nesbitt is classified as an Experienced expert for Polycythemia Vera, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John A. Nesbitt specialize in?

While Dr. John A. Nesbitt is a Hematology, they have specific expertise in Polycythemia Vera, Small Lymphocytic Lymphoma (SLL), and Hemolytic Crisis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. John A. Nesbitt participate in research or clinical trials?

Yes. Dr. John A. Nesbitt has published 1 articles and abstracts on conditions like Polycythemia Vera. You can view a list of Dr. John A. Nesbitt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nesbitt's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile